Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-12

Clinical Trial Update: Black Barley Study - Barley to Support Food and Drink Innovation (RI-B7-3) [NA]

View source ↗

Summary

A University of Aberdeen trial evaluated black barley as a functional ingredient related to Type 2 Diabetes and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Aberdeen | Conditions: Type 2 Diabetes | NA | Status: COMPLETED